Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Simulations Plus, Inc. logo

Simulations Plus, Inc. (SLP) Stock Ticker

NASDAQ: SLP · Technology · Software - Application
$18.46+0.00%
USD · as of 2026-09-28 · market cap $373.4M
Open SLP in TickrDownload for iPhone

SLP right now

Options expect by Oct 6±3.0%
Options expect by Oct 29±6.1%
Priced in for Oct 29 earnings±6.1%
IV rank (30-day)3% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full SLP picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on SLP
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Simulations Plus, Inc.

Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus, Cognigen, DILIsym, and Lixoft. Among its diverse software offerings are GastroPlus, which models the absorption and drug interactions of compounds in both human and animal subjects, as well as DDDPlus and MembranePlus for various simulations. The company also provides a range of products built on mechanistic and mathematical models, such as its quantitative systems pharmacology software like DILIsym, NAFLDsym, IPFsym, RENAsym, and MITOsym. Furthermore, Simulations Plus offers the ADMET Predictor, a chemistry-focused computer program that forecasts molecular properties from structural inputs, alongside MedChem Designer, MonolixSuite, and PKPlus for additional modeling and simulation needs. Beyond software, the company extends its expertise through various services, including contract research for population modeling and simulation, specialized training and consultation to advance pharmacometrics studies, and clinical-pharmacology consulting to aid in regulatory submissions. Simulations Plus serves a broad spectrum of clients globally, including pharmaceutical, biotechnology, agrochemical, cosmetic, and food companies, as well as academic institutions and regulatory bodies. The company was founded in 1996 and maintains its headquarters in Lancaster, California.

SLP stock facts

Ticker symbolSLP
ExchangeNASDAQ Global Select
SectorTechnology
IndustrySoftware - Application
Market cap$373.4M
CEOShawn O'Connor
Employees213
HeadquartersResearch Triangle Park, NC, US
IPO date1997-06-18
Websitewww.simulations-plus.com

What you can see for SLP on Tickr

Live SLP price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SLP report.

Rankings

Largest Technology companiesLargest companies by market cap

FAQ

What is the ticker symbol for Simulations Plus, Inc.?

The ticker symbol for Simulations Plus, Inc. is SLP, listed on the NASDAQ Global Select.

What is SLP?

Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus,…

HomeExploreMarketLists
All pages